{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:29:52Z","timestamp":1789014592837,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T00:00:00Z","timestamp":1418169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2014,12,10]],"date-time":"2014-12-10T00:00:00Z","timestamp":1418169600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1007\/s00520-014-2550-3","type":"journal-article","created":{"date-parts":[[2014,12,9]],"date-time":"2014-12-09T01:21:44Z","timestamp":1418088104000},"page":"1901-1906","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer Hospital"],"prefix":"10.1007","volume":"23","author":[{"given":"Benjamin W.","family":"Teh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon J.","family":"Worth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon J.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin A.","family":"Thursky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica A.","family":"Slavin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,10]]},"reference":[{"key":"2550_CR1","unstructured":"UK CR. 2013 November. Cancer stats report - myeloma, Cancer Research UK. Cancer Research United Kingdom <http:\/\/www.cancerresearchuk.org\/cancer-info\/cancerstats\/types\/myeloma\/incidence\/%3E. Accessed 29th November 2013"},{"key":"2550_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.blre.2014.01.004","volume":"28","author":"BW Teh","year":"2014","unstructured":"Teh BW, Harrison SJ, Pellegrini M, Thursky KA, Worth LJ, Slavin MA (2014) Changing treatment paradigms for patients with plasma cell myeloma: impact upon immune determinants of infection. Blood Rev 28:75\u201386","journal-title":"Blood Rev"},{"key":"2550_CR3","unstructured":"Quach H, Prince HM, Medical Scientific Advisory Group (2012) November. Clinical practice guidelines: multiple myeloma. 1st. Myeloma Foundation of Australia"},{"key":"2550_CR4","volume-title":"Spectrum of infections in myeloma patients treated solely with lenalidomide based regimens and autologous stem cell transplantation","author":"BW Teh","year":"2012","unstructured":"Teh BW, Thursky KA, Sedunary R, Khot A, Slavin MA, Harrison SJ (2012) Spectrum of infections in myeloma patients treated solely with lenalidomide based regimens and autologous stem cell transplantation. American Society of Microbiology, San Francisco"},{"key":"2550_CR5","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1086\/425004","volume":"39","author":"WG Nichols","year":"2004","unstructured":"Nichols WG, Guthrie KA, Corey L, Boeckh M (2004) Influenza infections after hematopoietic stem cell transplantation: risk factors, mortality, and the effect of antiviral therapy. Clin Infect Dis 39:1300\u20131306","journal-title":"Clin Infect Dis"},{"key":"2550_CR6","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1093\/cid\/cis844","volume":"56","author":"HH Hirsch","year":"2013","unstructured":"Hirsch HH, Martino R, Ward KN, Boeckh M, Einsele H, Ljungman P (2013) Fourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirus. Clin Infect Dis 56:258\u2013266","journal-title":"Clin Infect Dis"},{"key":"2550_CR7","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1016\/j.jaci.2013.06.006","volume":"132","author":"JK Yoo","year":"2013","unstructured":"Yoo JK, Kim TS, Hufford MM, Braciale TJ (2013) Viral infection of the lung: host response and sequelae. J Allergy Clin Immunol 132:1263\u20131276, quiz 1277","journal-title":"J Allergy Clin Immunol"},{"key":"2550_CR8","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1365-2141.2007.06705.x","volume":"138","author":"G Pratt","year":"2007","unstructured":"Pratt G, Goodyear O, Moss P (2007) Immunodeficiency and immunotherapy in multiple myeloma. Br J Haematol 138:563\u2013579","journal-title":"Br J Haematol"},{"key":"2550_CR9","doi-asserted-by":"publisher","first-page":"134081","DOI":"10.1155\/2012\/134081","volume":"2012","author":"S Kobold","year":"2012","unstructured":"Kobold S, Luetkens T, Bartels BM et al (2012) Longitudinal analysis of tetanus- and influenza-specific IgG antibodies in myeloma patients. Clin Dev Immunol 2012:134081","journal-title":"Clin Dev Immunol"},{"key":"2550_CR10","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1034\/j.1600-0609.2003.00028.x","volume":"70","author":"D Rapezzi","year":"2003","unstructured":"Rapezzi D, Sticchi L, Racchi O, Mangerini R, Ferraris AM, Gaetani GF (2003) Influenza vaccine in chronic lymphoproliferative disorders and multiple myeloma. Eur J Haematol 70:225\u2013230","journal-title":"Eur J Haematol"},{"key":"2550_CR11","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/01.md.0000232560.22098.4e","volume":"85","author":"RF Chemaly","year":"2006","unstructured":"Chemaly RF, Ghosh S, Bodey GP et al (2006) Respiratory viral infections in adults with hematologic malignancies and human stem cell transplantation recipients: a retrospective study at a major cancer center. Medicine (Baltimore) 85:278\u2013287","journal-title":"Medicine (Baltimore)"},{"key":"2550_CR12","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.3201\/eid1607.091691","volume":"16","author":"AR Tramontana","year":"2010","unstructured":"Tramontana AR, George B, Hurt AC et al (2010) Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia. Emerg Infect Dis 16:1068\u20131075","journal-title":"Emerg Infect Dis"},{"key":"2550_CR13","doi-asserted-by":"publisher","first-page":"5050","DOI":"10.1182\/blood-2010-11-319186","volume":"117","author":"SM Choi","year":"2011","unstructured":"Choi SM, Boudreault AA, Xie H, Englund JA, Corey L, Boeckh M (2011) Differences in clinical outcomes after 2009 influenza A\/H1N1 and seasonal influenza among hematopoietic cell transplant recipients. Blood 117:5050\u20135056","journal-title":"Blood"},{"key":"2550_CR14","first-page":"505","volume":"97","author":"P Musto","year":"1997","unstructured":"Musto P, Carotenuto M (1997) Vaccination against influenza in multiple myeloma. Br J Haematol 97:505\u2013506","journal-title":"Br J Haematol"},{"key":"2550_CR15","unstructured":"(2013) The Australian immunisation handbook. 10th Edition. In: Ageing AGDoHa (ed). Canberra: DoHA"},{"key":"2550_CR16","unstructured":"(2011) Consensus guidelines for Infection Prophylaxis including Vaccination in Multiple Myeloma. Paris, France"},{"key":"2550_CR17","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/j.bbmt.2005.07.007","volume":"11","author":"R Martino","year":"2005","unstructured":"Martino R, Porras RP, Rabella N et al (2005) Prospective study of the incidence, clinical features, and outcome of symptomatic upper and lower respiratory tract infections by respiratory viruses in adult recipients of hematopoietic stem cell transplants for hematologic malignancies. Biol Blood Marrow Transplant 11:781\u2013796","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-014-2550-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-014-2550-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-014-2550-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-014-2550-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T22:02:12Z","timestamp":1744149732000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-014-2550-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,10]]},"references-count":17,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["2550"],"URL":"https:\/\/doi.org\/10.1007\/s00520-014-2550-3","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,10]]},"assertion":[{"value":"21 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}